ReviewJournal of family medicine and primary care2026
Safety and effectiveness of topical dapsone in acne treatment: A review.
Review in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of dapsone nonjudicially in acne: Can this lead to resistance in leprosy? Comments on safety and effectiveness of topical dapsone in acne treatment: A review.Journal of family medicine and primary care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral dapsone is effective in treating several dermatologic conditions, including acne vulgaris. However, the rate of adverse effects of oral dapsone is a concern when prescribing it. Topical dapsone may mitigate these adverse effects and enhance the safety and tolerability of dapsone. Here, we review the published reports and studies to examine the efficacy and safety of topical dapsone in treating acne. A literature review was conducted using the PubMed database. The review considered patient and disease factors, such as the type of acne, acne location, patient gender, age, skin type, and race. Other factors, such as the duration and dosage of treatment, monotherapy versus combination therapy, adverse events, and safety profiles, were also compared. Topical dapsone was well tolerated and effective across a variety of acne presentations and patient subgroups. It showed a favorable safety profile, even in patients with comorbidities, such as G6PD deficiency. We conclude that topical dapsone is safe, effective, and well tolerated in the treatment of acne, contrary to its oral form.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.